Cronos Group Inc. (NASDAQ:CRON) is one of the High Growth Penny Stocks That Are Profitable in 2025. On July 2, Cronos Group Inc. (NASDAQ:CRON) announced expanding its reach in Europe by forging a new partnership with Dascoli Pharma AG.
Dascoli is a leader in distributing medical cannabis in Switzerland. As per the partnership, the company’s Peace Naturals medical cannabis flower will be sold through Dascoli’s Swiss network. The following strains of Peace Naturals would be available for patients in Switzerland, including GMO Cookies, Space Cake, Atomic Sour Grapefruit, Sonic Lemon Fuel, and Wedding Cake. This partnership aligns with Cronos Group Inc. (NASDAQ:CRON)’s strategy to increase its presence in key medical cannabis markets.
A close up of cannabis plants growing in an outdoor facility, symbolizing the product of the cannabinoid company.
Cronos Group Inc. (NASDAQ:CRON) is a global cannabis company that develops and sells a variety of cannabinoid products.
While we acknowledge the potential of CRON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.